Linda-Gail Bekker is the Director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town, and Chief Executive Officer of the Desmond Tutu Health Foundation. A physician-scientist and infectious disease specialist, her research interests include programmatic and action research around antiretroviral roll out and TB integration, and prevention of HIV in women, young people and men who have sex with men. Linda-Gail has recently been involved in several COVID-19 vaccine trials and co-leads the Sisonke Phase 3B study, which has seen the vaccination of 500,000 healthcare workers in South Africa. She has led numerous investigator-driven studies in HIV treatment, prevention and tuberculosis. She is a former IAS President, served as International Co-Chair of the 9th International AIDS Conference and 22nd International AIDS Conference, and co-chaired the 4th HIV Research for Prevention Conference in January 2021.
